References
- Ye YP, Sun HX, Pan YJ. Bergenin monohydrate from the rhizomae of Astilbe chinensis. Acta Crystallogr C 2004;60:397–8
- Wang G, Ma BJ. Overview of recent progress on bergenin. Anhui Zhong Yi Xue Yuan Xue Bao 2002;21:59–62
- Li RW, Leach DN, Myers SP, et al. A new anti-inflammatory glucoside from Ficus racemosa L. Planta Med 2004;70:421–6
- Lim HK, Kim HS, Choi HS, et al. Effects of bergenin, the major constituent of Mallotus japonicus against D-galactosamine induced hepatotoxicity in rats. Pharmacology 2001;63:71–5
- de Oliveira CM, Nonato FR, Villarreal CF, et al. Antinociceptive properties of bergenin. J Nat Prod 2011;74:2062–8
- Jiangsu New Medical College. Traditional medicine. Shanghai: Shanghai People’s Publishing House; 1999:2359
- Zhou D, Qin X, Zhang ZR, Huang Y. Physicochemical properties of bergenin. Pharmazie 2008;63:366–71
- Qin X, Yang Y, Fan TT, et al. Preparation, characterization and in vivo evaluation of bergenin-phospholipid complex. Acta Pharmacol Sin 2010;31:127–36
- Tan QY, Hu NN, Liu GD, et al. Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability. Arch Pharm Res 2012;35:499–508
- Jin X, Zhang ZH, Sun E, et al. Preparation of icariside II-phospholipid complex and its absorption across Caco-2 cell monolayers. Pharmazie 2012;67:293–8
- Kudsiova L, Lawrence MJ. A comparison of the effect of chitosan and chitosan-coated vesicles on monolayer integrity and permeability across Caco-2 and 16HBE14o-cells. J Pharm Sci 2008;97:3998–4010
- Lin YH, Mi FL, Chen CT, et al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 2007;8:146–52
- Jin Y, Song YP, Zhu X, et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 2011;33:1573–82
- Qin X, Zhou D, Zhang ZR, Huang Y. Determination of bergenin in rat plasma by high-performance liquid chromatography. Pharmazie 2007;62:323–6
- Mathot F, van Beijsterveldt L, Préat V, et al. Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. J Control Release 2006;111:47–55
- Grassi M, Cadelli G. Theoretical considerations on the in vivo intestinal permeability determination by means of the single pass and recirculating techniques. Int J Pharm 2008;229:95–105
- Dahan A, West BT, Amidon GL. Segmental-dependent membrane permeability along the intestine following oral drug administration: evaluation of triple single pass intestinal perfusion (TSPIP) approach in the rat. Eur J Pharm Sci 2009;36:320–9
- Peng Q, Zhang ZR, Sun X, et al. Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability. Mol Pharm 2010;7:565–75
- Yue PF, Yuan HL, Li XY, et al. Process optimization, characterization and evaluation in vivo of oxymatrine–phospholipid complex. Int J Pharm 2010;387:139–46
- Yanyu X, Yunmei S, Zhipeng C, Qineng P. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 2006;307:77–82
- Yue PF, Yuan HL, Xie H, et al. Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex in vivo. Drug Dev Ind Pharm 2008;34:708–18
- Patel MP, Patel RR, Patel JK. Chitosan mediated targeted drug delivery system: a review. J Pharm Pharm Sci 2010;13:536–57